Abstract

To investigate the effects of ferrostatin-1 (Fer-1) on cardiomyocyte hypoxia/reoxygenation injury and its mechanisms. The original generation of myocardial cells were extracted from 1~3 d newborn SD rats, which were randomly divided into normal control group (control), hypoxia reoxygenation (H/R) group and hypoxia reoxygenation + iron death inhibitors group (H/R + Fer-1). After 52 h of culture, cells in H/R group were added with 4 mmol/L Na2S2O4 solution. After 1 h of hypoxia, cells were reoxygenated with DMEM medium containing 10% calf serum for 3 h.The H/R+ Fer-1 group was pretreated with Fer-1 (2 μmol/L) for 24 h and then subjected to hypoxia and reoxygenation. The release rate of lactate dehydrogenase (LDH) was measured by UV spectrophotometry, the cell survival rate was measured by CCK-8 method, SOD was measured by xanthine oxidase method, MDA was measured by chemical coloration, and the changes of mitochondrial membrane potential and reactive oxygen species (ROS) were observed by immunofluorescence. Western blot was used to detect the expressions of ACSL4 and GPX4. Compared with the control group, the cell activity, SOD release and MMP level were decreased (P<0.05), the levels of LDH, MDA and ROS were increased (P<0.05), the protein expression of ACSL4 was increased (P<0.05), and the protein expression of GPX4 was decreased (P<0.05) in H/R group. Compared with the H/R group, the cell activity, SOD release and MMP level were increased (P<0.05), the level of LDH, MDA and ROS were decreased (P<0.05), the protein expression of ACSL4 was decreased (P<0.05), and the protein expression of GPX4 was increased (P<0.05) in H/R+Fer-1 group. Fer-1 can inhibit the production of intracellular reactive oxygen species by regulating ACSL4 and GPX4, thereby alleviating the hypoxia and reoxygenation injury of primary cardiomyocytes caused by iron death.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call